NO961770D0 - Alkyl, azido, alkoksy og fluorsubstituerte og kondenserte kinoksalindioner og deres anvendelse som glycinreseptorantagonister - Google Patents

Alkyl, azido, alkoksy og fluorsubstituerte og kondenserte kinoksalindioner og deres anvendelse som glycinreseptorantagonister

Info

Publication number: NO961770D0
Authority: NO; Norway
Prior art keywords: quinoxalinediones; azido; condensed; alkoxy; fluorine
Prior art date: 1993-11-05

Application number

NO961770A

Other languages

English (en)

Other versions

NO309981B1 (no

NO961770L (no

Inventor

Sui Xiong Cai

Eckard Weber

John F W Keana

Sunil Kher

Original Assignee

Acea Pharm Inc

Univ California

Oregon State

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-11-05

Filing date

1996-05-02

Publication date

1996-05-02

1993-11-05 Priority claimed from US08/148,259 external-priority patent/US5514680A/en

1996-05-02 Application filed by Acea Pharm Inc, Univ California, Oregon State filed Critical Acea Pharm Inc

1996-05-02 Publication of NO961770D0 publication Critical patent/NO961770D0/no

1996-07-05 Publication of NO961770L publication Critical patent/NO961770L/no

2001-04-30 Publication of NO309981B1 publication Critical patent/NO309981B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0459—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/36—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
- C07D241/38—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with only hydrogen or carbon atoms directly attached to the ring nitrogen atoms
- C07D241/40—Benzopyrazines
- C07D241/44—Benzopyrazines with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Optics & Photonics (AREA)
Diabetes (AREA)
Pain & Pain Management (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Hematology (AREA)
Obesity (AREA)
Endocrinology (AREA)
Emergency Medicine (AREA)
Psychiatry (AREA)
Heart & Thoracic Surgery (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Urology & Nephrology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)

NO961770A 1993-11-05 1996-05-02 Kinoksalinforbindelser, farmasøytisk preparat samt anvendelse NO309981B1 (no)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US14826893A	1993-11-05	1993-11-05
US08/148,259 US5514680A (en)	1992-06-22	1993-11-05	Glycine receptor antagonists and the use thereof
US20887894A	1994-03-11	1994-03-11
US08/289,603 US5631373A (en)	1993-11-05	1994-08-11	Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
PCT/US1994/012775 WO1995012417A1 (en)	1993-11-05	1994-11-07	Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones and the use thereof as glycine receptor antagonists

Publications (3)

Publication Number	Publication Date
NO961770D0 true NO961770D0 (no)	1996-05-02
NO961770L NO961770L (no)	1996-07-05
NO309981B1 NO309981B1 (no)	2001-04-30

Family

ID=27495799

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO961770A NO309981B1 (no)	1993-11-05	1996-05-02	Kinoksalinforbindelser, farmasøytisk preparat samt anvendelse

Country Status (10)

Country	Link
US (4)	US5631373A (no)
EP (1)	EP0732942A4 (no)
JP (1)	JP4164547B2 (no)
AU (1)	AU699353B2 (no)
CA (1)	CA2175795A1 (no)
FI (1)	FI961858A7 (no)
IL (1)	IL111533A (no)
NO (1)	NO309981B1 (no)
NZ (1)	NZ276892A (no)
WO (1)	WO1995012417A1 (no)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5631373A (en)	1993-11-05	1997-05-20	State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon	Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
EP0705834A1 (de) *	1994-07-27	1996-04-10	Ciba-Geigy Ag	Azaaliphatisch Überbrückte Chinoxalin-2,3-dione
EP0705835A1 (de) *	1994-09-01	1996-04-10	Ciba-Geigy Ag	Oxa- oder thiaaliphatisch überbrückte Chinoxalin-2,3-dione
US5566694A (en) *	1995-06-07	1996-10-22	Allegheny Plastics, Inc.	Continuous pickling tank with expandable seals
US5614508A (en) *	1995-06-07	1997-03-25	Warner-Lambert Company	Amino acid derivatives of substituted quinoxaline 2,3-dione derivatives as glutamate receptor antagonists
US5654303A (en) *	1995-06-07	1997-08-05	Warner-Lambert Company	Alkyl amine derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
MY132385A (en) *	1995-08-31	2007-10-31	Novartis Ag	2,3-dioxo-1,2,3,4-tetrahydro-quinoxalinyl derivatives
GB9604400D0 (en) *	1996-03-01	1996-05-01	Pfizer Ltd	Compounds useful in therapy
AUPN842196A0 (en) *	1996-03-05	1996-03-28	Fujisawa Pharmaceutical Co., Ltd.	New compound
AU3133697A (en) *	1996-06-05	1998-01-05	Warner-Lambert Company	Amide derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
AU5704898A (en) *	1996-12-16	1998-07-15	Warner-Lambert Company	Tricyclic quinoxaline derivatives as neuroprotective agents
TW526195B (en)	1997-06-10	2003-04-01	Novartis Ag	Crystal modifications of 1-(2,6-difluorobenzyl)-1H-1,2,3-triazole-4-carboxamide and their use
WO1999007701A1 (en) *	1997-08-05	1999-02-18	Sugen, Inc.	Tricyclic quinoxaline derivatives as protein tyrosine kinase inhibitors
IL125950A0 (en) *	1997-09-05	1999-04-11	Pfizer Prod Inc	Methods of administering ampa receptor antagonists to treat dyskinesias associated with dopamine agonist therapy
EP1175210A4 (en)	1999-03-19	2003-07-09	Enos Pharmaceuticals Inc	STRENGTHENING THE BIODAVAILABILITY OF DRUGS IN THE BRAIN
US6638981B2 (en)	2001-08-17	2003-10-28	Epicept Corporation	Topical compositions and methods for treating pain
BR0315008A (pt) *	2002-10-04	2005-08-09	Prana Biotechnology Ltd	Compostos neurologicamente ativos
JP2006514100A (ja) *	2002-10-24	2006-04-27	イーノス・ファーマシューティカルス・インコーポレーテッド	徐放性ｌ−アルギニン製剤並びに製造方法および使用方法
US20080145424A1 (en) *	2002-10-24	2008-06-19	Enos Phramaceuticals, Inc.	Sustained release L-arginine formulations and methods of manufacture and use
US20040152694A1 (en) *	2003-02-04	2004-08-05	Istvan Kurucz	Methods and compositions for treating inflammatory disorders of the airways
GB2398636A (en)	2003-02-21	2004-08-25	Ipsen Ltd	Method for determining the quantity of pre-synaptic neuromuscular blocking substance contained in a sample
CA2540202A1 (en) *	2003-09-29	2005-04-21	Enos Pharmaceuticals, Inc.	Sustained release l-arginine formulations and methods of manufacture and use
CA2683756A1 (en)	2006-04-14	2007-10-25	Prana Biotechnology Limited	Method of treatment of age-related macular degeneration(amd)
EP1902733A1 (en) *	2006-09-19	2008-03-26	Laboratorios Del Dr. Esteve, S.A.	Combination of a NMDA-receptor ligand and a compound with 5-HT6 receptor affinity
US7645558B2 (en) *	2007-06-13	2010-01-12	Xerox Corporation	Inkless reimageable printing paper and method
US20100316678A1 (en) *	2007-06-28	2010-12-16	Cnsbio Pty Ltd.	Combination methods and compositions for treatment of neuropathic pain
WO2009104080A2 (en)	2008-02-20	2009-08-27	Targia Pharmaceuticals	Cns pharmaceutical compositions and methods of use
ES2436195T3 (es)	2008-06-16	2013-12-27	Merck Patent Gmbh	Derivados de la quinoxalinadiona
EP2338492A1 (en)	2009-12-24	2011-06-29	Universidad del Pais Vasco	Methods and compositions for the treatment of alzheimer

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3992378A (en) *	1973-12-26	1976-11-16	Eli Lilly And Company	Fluoralkyl quinoxadinediones
US3962440A (en) *	1973-12-26	1976-06-08	Eli Lilly And Company	Quinoxaline compounds as hypnotic agents
DE2446543A1 (de) *	1974-09-28	1976-04-15	Hoechst Ag	Wasserunloesliche monoazomethinfarbstoffe, verfahren zu ihrer herstellung und ihre verwendung
DE2451049A1 (de) *	1974-10-26	1976-04-29	Hoechst Ag	Perinon-verbindungen, verfahren zu ihrer herstellung und ihre verwendung als farbmittel
DE2847285A1 (de) *	1978-10-31	1980-05-14	Hoechst Ag	Monoazoverbindungen, verfahren zu ihrer herstellung und ihre verwendung
US4659713A (en) *	1984-10-01	1987-04-21	International Minerals & Chemical Corp.	Quinoxalinedione compounds useful for controlling coccidiosis
US4803270A (en) *	1986-03-10	1989-02-07	Sumitomo Chemical Company, Limited	Process of producing fluoroaniline derivatives
US4812458A (en) *	1986-09-16	1989-03-14	A/S Ferrosan	6,7-disubstituted-2,3-dihydroxyquinoxaline compounds, pharmaceutical compositions thereof, and their use as neuroleptics
DK146787A (da) *	1987-03-23	1988-09-24	Ferrosan	Heterocykliske forbindelser, deres fremstilling og anvendelse
NO179551C (no) *	1987-11-10	1996-10-30	Novo Nordisk As	Analogifremgangsmåte for fremstilling av terapeutisk virksomme kinoxalinforbindelser
DK160941C (da) *	1988-06-28	1991-10-21	Novo Nordisk As	Kondenserede 2,3-dihydroxypyraziner, fremgangsmaade til deres fremstilling og farmaceutiske praeparater, hvori forbindelserne indgaar
DK716188D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Quinoxalinforbindelser, deres fremstilling og anvendelse
US5308845A (en) *	1988-12-22	1994-05-03	Novo Nordisk A/S	Quinoxaline compounds and their preparation and use
DK715888D0 (da) *	1988-12-22	1988-12-22	Ferrosan As	Quinoxalinforbindelser, deres fremstilling og anvendelse
US5182258A (en)	1989-03-20	1993-01-26	Orbon Corporation	Systemic delivery of polypeptides through the eye
US5055465A (en) *	1989-05-31	1991-10-08	Berlex Laboratories, Inc.	Imidazoquinoxalinones, their aza analogs and process for their preparation
US4975430A (en) *	1989-06-16	1990-12-04	The State Of Oregon Acting By And Through The State Board Of Education On Behalf Of The Oregon Health Sciences University	CNQX and its analogs as therapeutics for degenerative neural diseases
DK69790D0 (da) *	1990-03-16	1990-03-16	Novo Nordisk As	Heterocykliske forbindelser, deres fremstilling af anvendelse
US5268378A (en) *	1990-05-31	1993-12-07	Merck Sharp & Dohme, Limited	Dioxo-tetrahydroquinoline derivatives
ES2150417T3 (es) *	1990-11-06	2000-12-01	Yamanouchi Pharma Co Ltd	Derivados de pirazina fusionados.
WO1992011245A1 (en) *	1990-12-20	1992-07-09	Warner-Lambert Company	2-acylamido derivatives of 3,4-dihydro-3-oxo-quinoxaline having pharmaceutical activity
PT99864B (pt) *	1990-12-21	1999-06-30	Schering Ag	Processo para a preparacao de novas composicoes farmaceuticas contendo antagonistas de receptor de quisqualato
DK73091D0 (da) *	1991-04-22	1991-04-22	Novo Nordisk As	Quinoxalinforbindelser, deres fremstilling og anvendelse
US5196421A (en) *	1991-06-05	1993-03-23	Eli Lilly And Company	Excitatory amino acid receptor antagonists in methods for the use thereof
JPH05117276A (ja) *	1991-10-23	1993-05-14	Sumitomo Pharmaceut Co Ltd	新規な３環性キノキサリンジオン誘導体
PT647137E (pt) *	1992-06-22	2008-11-24	Univ California	Antagonistas dos receptores da glicina e a sua utilização
DE4220616C2 (de) *	1992-06-24	1994-12-22	Byk Gulden Lomberg Chem Fab	Dexniguldipin zur intravenösen Verabreichung
US5352683A (en) *	1993-03-05	1994-10-04	Virginia Commonwealth University Medical College Of Virginia	Method for the treatment of chronic pain
US5631373A (en) *	1993-11-05	1997-05-20	State Of Oregon, Acting By And Through The Oregon State Board Of Higher Education, Acting For And On Behalf Of The Oregon Health Sciences University And The University Of Oregon, Eugene Oregon	Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones
DE4439492A1 (de) *	1994-10-25	1996-05-02	Schering Ag	Neue Chinoxalindionderivate, deren Herstellung und Verwendung in Arzneimitteln
US6172065B1 (en) *	1997-03-04	2001-01-09	Warner-Lambert Company	Urea and thiourea derivatives of substituted quinoxaline 2,3-diones as glutamate receptor antagonists
US6166019A (en) *	1998-07-16	2000-12-26	Abbott Laboratories	Piperazinyl pyrimidine dione compounds selective for adrenoceptors

1994
- 1994-08-11 US US08/289,603 patent/US5631373A/en not_active Expired - Lifetime
- 1994-11-06 IL IL11153394A patent/IL111533A/en not_active IP Right Cessation
- 1994-11-07 CA CA002175795A patent/CA2175795A1/en not_active Abandoned
- 1994-11-07 JP JP51345295A patent/JP4164547B2/ja not_active Expired - Fee Related
- 1994-11-07 AU AU11723/95A patent/AU699353B2/en not_active Ceased
- 1994-11-07 WO PCT/US1994/012775 patent/WO1995012417A1/en not_active Ceased
- 1994-11-07 NZ NZ276892A patent/NZ276892A/xx not_active IP Right Cessation
- 1994-11-07 EP EP95902458A patent/EP0732942A4/en not_active Withdrawn
1996
- 1996-05-02 FI FI961858A patent/FI961858A7/fi not_active Application Discontinuation
- 1996-05-02 NO NO961770A patent/NO309981B1/no not_active IP Right Cessation
1997
- 1997-01-31 US US08/792,872 patent/US5977107A/en not_active Expired - Fee Related
1999
- 1999-08-18 US US09/376,536 patent/US6147075A/en not_active Expired - Fee Related
2000
- 2000-09-13 US US09/661,475 patent/US6251903B1/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
CA2175795A1 (en)	1995-05-11
US5631373A (en)	1997-05-20
IL111533A (en)	2001-06-14
JPH09504794A (ja)	1997-05-13
US6251903B1 (en)	2001-06-26
NO309981B1 (no)	2001-04-30
US6147075A (en)	2000-11-14
IL111533A0 (en)	1995-01-24
US5977107A (en)	1999-11-02
EP0732942A4 (en)	2000-03-22
NO961770L (no)	1996-07-05
AU699353B2 (en)	1998-12-03
JP4164547B2 (ja)	2008-10-15
NZ276892A (en)	2000-01-28
EP0732942A1 (en)	1996-09-25
AU1172395A (en)	1995-05-23
FI961858A7 (fi)	1996-07-04
FI961858A0 (fi)	1996-05-02
WO1995012417A1 (en)	1995-05-11

Publication	Publication Date	Title
NO961770D0 (no)	1996-05-02	Alkyl, azido, alkoksy og fluorsubstituerte og kondenserte kinoksalindioner og deres anvendelse som glycinreseptorantagonister
NO996178D0 (no)	1999-12-14	4-aminopyrrol(3,2-d)pyrimidiner som neuropeptid y- reseptorantagonister
MX209959B (es)	2002-08-26	4-(3-heterociclil-1-benzoil)pirazoles
DK0912559T3 (da)	2003-03-10	Kondenserede heterocykliske forbindelser som proteintyrosinkinaseinhibitorer
DE59915235D1 (de)	2011-02-17	Gesteuerte gleichrichterbrücke mit überspannungsschutz
DE69837355D1 (de)	2007-04-26	Kugelkette
DE69824566D1 (de)	2004-07-22	Calciumrezeptor-inhibitoren
BR9608155A (pt)	1999-02-09	Amino fenil uracilas substituídas
DK0913154T3 (da)	2003-03-03	Antipsoriatisk virksom neglelak
DE69911095D1 (de)	2003-10-16	Federausgleichsvorrichtung
ID24726A (id)	2000-08-03	Antagonis-antagonis reseptor trombin
ID24162A (id)	2000-07-13	Antagonis-antagonis reseptor vitronektin
ID26086A (id)	2000-11-23	Ligan-ligan reseptor 5ht1 azabisiklik
DK1087952T3 (da)	2004-10-04	Banzazolforbindelser samt deres anvendelse
DE59913697D1 (de)	2006-09-07	Nagelmagazin
FI974130L (fi)	1999-05-05	Puskurinhallinta
NO972612D0 (no)	1997-06-06	Pyridazoner som endotelinreseptorantagonister
FI981255L (fi)	1999-12-04	Jousinivelrakenne
FI943359L (fi)	1995-01-16	Atsasykliset-heterosykliset yhdisteet angiotensiini II reseptoriantagonisteina
ID26508A (id)	2001-01-11	Oksim-oksim tersubstitusi sebagai antagonis-antagonis neurokinin
DK0956283T3 (da)	2003-10-06	Substituerede phenyltriazolin(thi)oner samt deres anvendelse som herbicider
DK0966464T3 (da)	2003-09-22	Substituerede 2,4-diaminopyrimidiner
KR980000390U (ko)	1998-03-30	손톱소제용가위
KR980000389U (ko)	1998-03-30	손톱소제용가위
IT243744Y1 (it)	2002-03-06	Canna

Legal Events

Date	Code	Title	Description
2004-11-22	MM1K	Lapsed by not paying the annual fees